Adverse events95

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 95

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Activated partial thromboplastin time prolonged	Investigations	Cixutumumab and Temsirolimus	14	175	25
other	Alanine aminotransferase	Investigations	Cixutumumab and Temsirolimus	32	175	60
other	Alkaline phosphatase increased	Investigations	Cixutumumab and Temsirolimus	32	175	175
other	Aspartate aminotransferase increased	Investigations	Cixutumumab and Temsirolimus	31	175	132
other	Blood Bilirubin increased	Investigations	Cixutumumab and Temsirolimus	12	175	29
other	Cholesterol, High	Investigations	Cixutumumab and Temsirolimus	41	175	139
other	Creatinine increased	Investigations	Cixutumumab and Temsirolimus	19	175	192
other	Hyperglycemia	Metabolism and nutrition disorders	Cixutumumab and Temsirolimus	61	175	915
other	Hyperkalemia	Metabolism and nutrition disorders	Cixutumumab and Temsirolimus	8	175	21
other	Hypertriglyceridemia	Metabolism and nutrition disorders	Cixutumumab and Temsirolimus	40	175	159
other	Hypoalbuminemia	Metabolism and nutrition disorders	Cixutumumab and Temsirolimus	51	175	509
other	Hypocalcemia	Metabolism and nutrition disorders	Cixutumumab and Temsirolimus	26	175	157
other	Hypokalemia	Metabolism and nutrition disorders	Cixutumumab and Temsirolimus	15	175	57
other	Hyponatremia	Investigations	Cixutumumab and Temsirolimus	30	175	133
other	Hypophosphatemia	Metabolism and nutrition disorders	Cixutumumab and Temsirolimus	19	175	52
other	INR increased	Metabolism and nutrition disorders	Cixutumumab and Temsirolimus	31	175	107
other	Lymphocyte count decrease	Investigations	Cixutumumab and Temsirolimus	18	175	98
other	Neutrophil count decrease	Investigations	Cixutumumab and Temsirolimus	21	175	59
other	Platelet Count decrease	Investigations	Cixutumumab and Temsirolimus	50	175	404
other	White blood cell decrease	Investigations	Cixutumumab and Temsirolimus	44	175	285

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01016015/events

API reference For AI assistants

Adverse events95

Sources 3

Read this list from software.